Alere’s Device Recall Stirs More Questions About Abbott DealBy
Abbott says it’s disappointed; review of deal continues
Analysts say financial filing from Alere expected by Friday
Alere Inc. is recalling a device that monitors patients taking a sensitive blood-thinning medicine, a move that may further destabilize its pending acquisition by Abbott Laboratories.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.